SURMODICS

surmodics-logo

SurModics provides surface modification and in vitro diagnostic technologies to the healthcare industry. It also develops and commercializes highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the companyโ€™s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities.

#SimilarOrganizations #People #Financial #Event #Website #More

SURMODICS

Social Links:

Industry:
Biotechnology Chemical Health Care Manufacturing Medical Device

Founded:
1979-01-01

Address:
Eden Prairie, Minnesota, United States

Country:
United States

Website Url:
http://www.surmodics.com

Total Employee:
251+

Status:
Active

Contact:
9528292743

Total Funding:
125 M USD

Technology used in webpage:
Domain Not Resolving Euro Google Font API Google Tag Manager Google Analytics Content Delivery Network Amazon Font Awesome Global Site Tag Mobile Non Scaleable Content


Similar Organizations

agamatrix-logo

AgaMatrix

AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care.

biolase-logo

Biolase

Biolase develops lasers and related productsย for providing biological treatments that reduce pain.

femasys-logo

Femasys

Femasys engages in R&D and manufacture of medical devices for women's healthcare.

imaging3-logo

Imaging3

Imaging3 is a global manufacturer of medical devices, equipment, and imaging tools for the healthcare industry.

miach-orthopaedics-logo

Miach Orthopaedics

Miach Orthopaedics is a medical device company that designs technologies intended to facilitate new tissue growth.

neonc-technologies-logo

NEONC Technologies

NEONC Technologies develops intranasal inhalation dosing therapies for the treatment of brain and lung cancers.

neuronetics-logo

Neuronetics

Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.

viewray-logo

ViewRay

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

woven-orthopedic-technologies-logo

Woven Orthopedic Technologies

Woven Orthopedic Technologies is a developer of fabric technologies for the neuro-musculoskeletal industry.

zynex-logo

Zynex

Zynex engineers, manufactures, markets and sells its own design of medical devices in three subsidiaries.

Current Employees Featured

pearse-odonohue_image

Pearse O'Donohue
Pearse O'Donohue VP of Operations @ SurModics
VP of Operations
2007-10-01

not_available_image

Arthur J. Tipton
Arthur J. Tipton Senior Vice President and General Manager @ SurModics
Senior Vice President and General Manager

not_available_image

Stephen C. Hathaway
Stephen C. Hathaway CFO @ SurModics
CFO
1996-09-01

not_available_image

Nusrath Sultana
Nusrath Sultana VP of clinical affairs @ SurModics
VP of clinical affairs
2020-02-01

Stock Details


Company's stock symbol is NASDAQ:SRDX

Acquisitions List

Date Company Article Price
2021-07-06 Vetex Medical Vetex Medical acquired by SurModics 39.9 M USD
2016-01-11 NorMedix NorMedix acquired by SurModics 14 M USD
2015-11-20 Creagh Medical Creagh Medical acquired by SurModics 30 M EUR
2007-08-13 BioFX Laboratories BioFX Laboratories acquired by SurModics 22.7 M USD
2007-08-01 Brookwood Pharmaceuticals Brookwood Pharmaceuticals acquired by SurModics 62 M USD
2005-01-19 InnoRx InnoRx acquired by SurModics N/A

Investors List

midcap-financial_image

MidCap Financial

MidCap Financial investment in Post-IPO Debt - SurModics

Key Employee Changes

Date New article
2020-02-04 Surmodics hires former Edwards Lifesciences exec as clinical affairs VP

Official Site Inspections

http://www.surmodics.com Semrush global rank: 2.57 M Semrush visits lastest month: 7.09 K

  • Host name: 198.49.23.144
  • IP address: 198.49.23.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "SurModics"

Surmodics: Medical Device Coatings & In Vitro โ€ฆ

Surmodics is a leading provider of chemical components for in vitro diagnostic tests and microarrays. We enable sensitive, reproducible, and robust diagnostic technologies. shop.surmodics.com. Follow us on social: Corporate. 9924 West โ€ฆSee details»

SurModics - Crunchbase Company Profile & Funding

SurModics provides surface modification and in vitro diagnostic technologies to the healthcare industry. It also develops and commercializes highly โ€ฆSee details»

Surmodics, Inc. - LinkedIn

Surmodics, Inc. | 9,946 followers on LinkedIn. To improve the detection and treatment of disease. | Surmodics is the global leader in surface modification technologies for intravascular medical ...See details»

Contact Us - Surmodics, Inc

Corporate Headquarters Surmodics, Inc. 9924 West 74th Street Eden Prairie, MN 55344-3523 United States Phone: +1 952-500-7000 Toll-free: 1-866-787-6639See details»

About - Surmodics

Surmodics IVD, Inc. 9924 West 74th Street Eden Prairie, MN 55344 USA Direct: 952-500-7200 Fax: 952-500-7201See details»

SurModics - The Org

SurModics, Inc. is a leading provider of surface modification, drug delivery, and in vitro diagnostic technologies to the healthcare industry. Platform FeaturesSee details»

Surmodics, Inc. Company Profile | Eden Prairie, MN | Competitors ...

Company Description: Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic โ€ฆSee details»

SurModics - Leadership Team - The Org

The Leadership Team at SurModics drives the strategic direction and operational excellence of the company, overseeing core functions such as finance, product development, legal, and โ€ฆSee details»

Governance Surmodics, Inc. - MarketScreener.com

Feb 16, 2014 Organization Committee Chair 2014-05-08 Lisa Heine. 62 year ... Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and โ€ฆSee details»

SurModics - businessabc.net

Apr 9, 2025 SurModics, Inc. has a long history of incubating and commercializing medical innovations. Founded in 1979, SurModics has enjoyed decades of success by providing the โ€ฆSee details»

Surmodics Company Profile | Management and Employees List

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) โ€ฆSee details»

Surmodics - Crunchbase Company Profile & Funding

Organization. Surmodics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Surmodics is located in Eden Prairie, Minnesota, United โ€ฆSee details»

About Surmodics, Inc. โ€” Sublimeโ„ข Radial Access Platform

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) โ€ฆSee details»

SurModics Company Profile - Office Locations, Competitors ... - Craft

Oct 28, 2024 SurModics has 5 employees across 3 locations and $126.08 m in annual revenue in FY 2024. See insights on SurModics including office locations, competitors, revenue, โ€ฆSee details»

Surmodics, Inc. | Medical Device Supplier Directory | Qmed

A key focus for Surmodics is supporting our customer's device qualifications with robust testing capabilities including lubricity, durability, clinical track, particulate, and more. Contact. โ€ฆSee details»

SurModics - Funding, Financials, Valuation & Investors - Crunchbase

SurModics is registered under the ticker NASDAQ:SRDX . Their stock opened with $7.00 in its Mar 4, 1998 IPO. SurModics is funded by MidCap Financial. SurModics has acquired 6 โ€ฆSee details»

Performance Coatings โ€” Surmodics, Inc.

The Surmodics drug-delivery coatings utilize innovative technology to meet a variety of clinical needs โ€“ from short-term to long-term controlled release โ€“ and across a range of compounds โ€ฆSee details»

How Minnesota's Surmodics found itself in the FTCโ€™s crosshairs

Apr 28, 2025 Surmodics received $25 million up front with the chance to make an additional $67 million by meeting certain milestones. The agreement also allowed the company to make more โ€ฆSee details»

Surmodics Enters into Definitive Agreement to be Acquired by โ€ฆ

May 29, 2024 The proxy statement, any other relevant documents, and all other materials filed with the SEC concerning Surmodics will be available free of charge via the SECโ€™s website โ€ฆSee details»

SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to โ€ฆ

5 days ago For the quarter ended March 2025, SurModics (SRDX) reported revenue of $28.09 million, down 12.1% over the same period last year. EPS came in at -$0.13, compared to โ€ฆSee details»

linkstock.net © 2022. All rights reserved